TumorGen
Darren Finlay is an Advisor at TumorGen and a previous employee of U.C.D., Sanford Burnham Prebys Medical Discovery Institute, and Sanford Burnham Prebys Medical Discovery Institute.
Darren Finlay has a B.Sc. and Ph.D. in Pharmacology, cell and molecular biology, signal transduction and cancer from University College Dublin.
This person is not in the org chart
TumorGen
TumorGen is developing a novel drug discovery platform to identify unseen therapeutic targets associated with cancer metastasis. Their patented technology is used to capture circulating metastatic cancer cell clusters (MCCCs).